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Abstract
Background: Targeting quorum sensing is an alternative approach to antibiotics.Targeting quorum sensing-regulated virulence 
will disarm the pathogen without exerting pressure on its growth. As a result, emergence of   resistance is avoided and the im- 
mune system can easily eradicate bacteria.
Objectives: Investigation of  the possible inhibition of  quorum sensing-regulated virulence of  Pseudomonas aeruginosa by glycer-
yltrinitrate.
Methods: The quorum sensing inhibiting activity of  glyceryl trinitrate was assessed by inhibition of  violacein production in 
Chromobacterium violaceum ATCC 12472. Its ability to inhibit pyocyanin, protease, biofilm and tolerance to oxidative stress was 
evaluated. Docking study was performed to study the interference of  glyceryl trinitrate with the binding of  autoinducers with 
LasR and rhlR receptors.
Results: Glyceryl trinitrate exerted a significant biofilm inhibiting and eradicating activities. It decreased the production of  
quorum-sensing dependent violacein production. It significantly inhibited the production of  pyocyanin and protease and dimin-
ished the tolerance against oxidative stress. Molecular docking study showed that glyceryl trinitrate interferes with the binding of  
autoinducers to their receptors. It could bind to Las Rand rhlr receptors with binding energy of  -93.47 and -77.23, respectively. 
Conclusion: Glyceryl trinitrate can be an antivirulence agent in the treatment of  Pseudomonas aeruginosa topical infections such as 
burn infections.
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Introduction
Quorum sensing (QS) is a cell-to-cell communication sys- 
tem between bacterial cells1. It is based on the secretion 
of  signaling molecules or autoinducers by the bacterial 
cells. Autoinducer molecules accumulate in the growth 
medium during bacterial growth and they reflect the 
population density. When a threshold concentration is 
reached, the expression of   genes is changed. The genes 
of  virulence and biofilm formation are controlled in 
many pathogenic bacteria by QS2. Autoinducers in many 
gram-negative bacteria are acyl homoserine lactones 
(AHLs). The genes involved in AHL-based QS systems 
are referred to as luxI-like and luxR-like genes. The en- 
zyme needed for the synthesis of  an AHL is encoded by 
luxI-like gene, while the receptor of  that specific AHL is 
encoded by the cognate luxR-like gene.
When the AHL signal is bound to the receptor, the tran-
scription of  target genes is regulated3. P. aeruginosa is an 
opportunistic pathogen that causes various infections, 
such as burn infections, especially in immuno suppressed 
patients4. QS enables P. aeruginosa to produce virulence 
factors involved in establishing infections. The virulence 
genes in P. aeruginosa are regulated by two AHL lux-like 
systems, lasI/lasR and rhlI/rhlR. In the lasI/lasR system, 
lasI synthesizes 3-oxo-dodecanoylhomoserine lactone 
(3-oxo-C12HSL)5. When exceeding a certain concentra-
tion, 3-oxo-C12HSL binds to the cytoplasmic receptor 
LasR and induces the expression of  genes that produce 
virulence factors, such as proteases, elastases and exotoxin 
A6. Moreover, rhlI is regulated by LasR- 3-oxo-C12HSL 
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and it is responsible for the synthesis of  butanoylhomo-
serine lactone (C4HSL). Butanoyl homo- serine lactone 
binds to the receptor RhlR and activates the genes en-
coding pyocyanin, elastases, siderophores, and rhamno-
lipids7. Biofilm formation in P. aeruginosa is also controlled 
by QS regulated factors such as rhamno- lipids and sid-
erophores, and swarming motility. Bacteria growing in 
biofilm mode are present as different phenotypes from 
planktonic cells, so they are highly resistant to antibiotic 
therapy8. The abuse of  antibiotics in the treatment of  
burn wound infections led to the emergence of  antibi-
otic-resistant microorganisms9. As a result, alternative 
therapeutic strategies are necessary. Due to the role of  
QS in regulation of  virulence factors, it is an ideal target 
for novel anti-virulence drugs10.
Glyceryl trinitrate (GTN) is an agent used in the treat- 
ment of  hypertension. However, it was found to possess 
wound healing and antimicrobial activities11,12.
The antibiofilm activity of  GTN was previously reported. 
It was found to be an effective catherter lock solution 
in combination with ethanol and citrate13,14. Moreover, 
GTN combined with caprylic acid was able to eradicate 
biofilms of  Staphylococcus aureus¸ Staphylococcus epidermidis, 
Pseudomonas aeruginosa and candida albicans14.
GTN exerted antimicrobial activity against planktonic 
Candida albicans at high concentrations ranging from 
0.15% to 0.3%12. GTN is approved from FDA to be used 
as an ointment for anal fissures with concentrations up 
to 0.4%15.
The objective of  this study was to investigate the abil-
ity of  glyceryl trinitrate to inhibit QS-mediated virulence 
factors and biofilm formation in P. aeruginosa PAO1 strain 
and five clinical isolates from burn wound infections.
 
Materials and methods 
Media and chemicals
Luria-Bertani (LB) broth, LB agar, tryptone and peptone 
were obtained from Lab M Limited (Lancashire, United 
Kingdom). Mueller Hinton broth, Mueller Hinton agar 
and Tryptone soya broth were the products of  Oxoid 
(Hampshire, UK). Azocasein was purchased from Sigma 
(St. Louis, USA) and glyceryl trinitrate (Stock so- lution 
with a concentration of  1 mg/ml) from POHL-Boskamp, 
Gmbh&Co., Hohenlockstedt, Germany. Other chemicals 
were of  pharmaceutical grade.
Bacterial strains
Pseudomonas aeruginosa PAO1 strain, Chromobacterium viola-
ceum ATCC12472 and five clinical isolates obtained from 
patients with burn wound infections in Zagazig Univer-
sity hospitals were used in this study. The clinical isolates 
were obtained from the stock culture of  the Microbiol-
ogy and Immunology Department, Faculty of  Pharmacy, 
Zagazig University. Pseudomonas aeruginosa PAO1 and Chro-
mobacterium violaceum ATCC 12472 were purchased from 
ATCC organization, Manassas, Virginia, USA.
Determination of  minimum inhibitory concentra-
tion (MIC)
To determine the minimum inhibitory concentration of  
GTN, the agar dilution method was used according to 
the Clinical Laboratory and Standards Institute Guide-
lines (CLSI)16. Overnight cultures of  the tested strains 
were prepared in tryptone soya broth (TSB). The cultures 
were diluted with Mueller-Hinton broth to have turbidi-
ties matching that of  0.5 McFarland Standard and then 
diluted 1:10 with sterile saline so that approximate cell-
density of  107 CFU/ml for each strain was achieved. A 
standardized inoculum was delivered to the surface of  
Mueller-Hinton agar plates with different GTN dilutions 
to achieve a final inoculum of  approximately 104 CFU per 
spot on the agar. The plates were incubated  at 37°C for 
20 h and the MIC was calculated as the lowest concentra-
tion of  the GTN that inhibited the visible growth in the 
wells.
Violacein inhibition assay
The effect of  GTN on quorum sensing inhibition was 
investigated by testing the ability of  GTN to inhibit quo-
rum sensing-dependent violacein production in Chro-
mobacterium violaceum ATCC 12472 according to Blosser 
and Gray17. C. violaceum was grown in LB broth, and after 
overnight incubation, the culture was diluted to achieve 
an approximate cell density of  106 CFU/ml. Aliquots of  
100 μl of  the adjusted culture were used to inoculate 5 
ml of  LB broth in the absence and presence of  GTN. 
After incubation at 30°C for 24 h, aliquots of  100 µl of  
sodium dodcyl sulphate (10%) were added to aliquots of  
200 µl of  each culture to lyse the cells. To extract viola-
cein, water saturated butanol (900 µl) was added followed 
by vortexing and centrifugation at 12,000 rpm for 5 min-
utes to separate the organic phase. The concentration of  
violacein in the organic phase was measured at 585 nm by 
microplate reader (Biotek, USA).
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Assay of  biofilm formation inhibition and eradica-
tion
The ability of  P. aeruginosa strains to produce biofilm was 
investigated by using the modified method of  Stepa-
novic et al.18 Overnight cultures of  the tested strains were 
used to prepare bacterial suspensions with densities of  
1 × 106 CFU/ ml using TSB for dilution. The bacterial 
suspensions were added in aliquots of  100μl to the wells 
of  96 well sterile microtiter plates with rounded bottom. 
The plates were incubated for 24 h at 37°C and then the 
planktonic cells were removed by aspiration of  the con-
tents of  the microtiter plates. The wells were washed 3 
times with sterile phosphate buffered saline (PBS, pH 7.2) 
and aliquots of  100 μl of  99% methanol were added to 
fix the attached bacteria and left for 20 minutes. The wells 
were stained using crystal violet (1%) for 20 minutes and 
the wells were washed with distilled water to remove any 
excess dye.
The plates were left to air dry and the dye was eluted 
by addition of  33% glacial acetic acid. The contents of  
the microtiter plate were transferred to a new plate and 
the optical densities were measured with a spectrofluo-
rimeter (Biotek, USA) at 590 nm. Measurements were 
performed in triplicate. To identify the magnitude of  
biofilm formation, the cut-off  optical density (ODc) was 
calculated as three times standard deviations above the 
mean OD of  the negative control. According to the cri-
teria of  Stepanovic et al.18, the tested strains were either 
non-biofilm producer (OD ≤ ODc), weak biofilm pro-
ducer (OD >ODc,  but ≤ 2x ODc), moderate biofilm 
producer(OD>2x ODc, but≤4x ODc), or strong biofilm 
producer (OD> 4x ODc).
To test the anti-biofilm activity of  GTN, the previous 
procedure was followed in the absence and presence of  
0.25 mg/ml of  GTN. The percentage of  biofilm inhibi-
tion was calculated by the following formula 
% of   biofilm inhibition = (OD in absence of  GTN-OD 
in presence of  GTN)/ OD in absence of  GTN
 
To test the ability of  GTN to eradicate established 
biofilms,100μl aliquots of  GTN (0.25mg/ ml) were add-
ed to the wells of  microtiter plates with preformed bio-
films. The plates were incubated for 24 h at 37°C and 
treated as previously described in biofilm formation as-
say. The optical density was measured at 590 nm using 
spectrofluorimeter (Biotek, USA) and the percentage of  
biofilm eradication was calculated.
Protease assay
The proteolytic activity was determined by the azocasein-
assay according to Kessleret al.19 Azocasein (0.3%) was 
prepared in 0.05M Tris-HCl and 0.5M CaCl2 (pH 7.5) 
and 1ml was added to 150 μl of  the free cell culture su-
pernatant. After incubation of  the mixture for 15 minutes 
at 37°C, 0.5 ml of  trichloroacetic acid (10%) was added 
to terminate the reaction. The precipitated azocasein was 
removed by centrifugation and the absorbance of  the su-
pernatants was measured at a wave length of  400 nm us-
ing Biotek Spectrofluorimeter (Biotek, USA).
Pyocyanin assay
The assay was performed according to Das and Mane-
field20. The tested strains were grown overnight in LB 
broth and diluted to reach OD600 of  0.4. Ten μl of  the di-
luted suspension of  each strain was inoculated in 1 ml of  
LB broth in the absence and presence of  GTN (0.25mg/
ml). The cultures were incubated at 37°C for 48h and the 
tubes were centrifuged at 10,000 rpm for 10 minutes. The 
absorbance of  pyocyanin in the supernatant was mea-
sured at 691nm using Biotek Spectrofluorimeter (Biotek, 
USA). The experiment was performed in triplicate and 
the mean of  the results and the percentage of  pyocyanin 
inhibition were calculated.
 
Sensitivity to oxidative stress
The ability of  GTN to interfere with resistance to oxi-
dative stress mediated by pyocyanin was performed by a 
disk assay as modified from the method of  Hassett et al.21 
Aliquots of  100μl from overnight cultures of  the tested 
bacterial strains in TSB were uniformly spread on the sur-
face of  TSA plates with 2% agar with and without GTN 
(0.25mg/ml). Sterile filter paper disks of  6 mm diameter 
were put on the surface of  TSA plates. The disks were 
loaded with 10 μl of   1.5% H2O2.
The plates were incubated at 37°C for 24 h and the diam-
eters of  the zones of  inhibition were measured.
Docking study
The crystal structure of  P. aeruginosa LasR ligand bind-
ing domain was retrieved from Protein Data Bank (PDB 
ID: 2UV0)22 and the rhlr receptor model (ID:P54292.1)
was obtained from protein model portal (Protein Model 
Portal)23. This study was carried out on GTN along with 
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the co-crystalized natural ligand, 3-oxo-dodecanoyl ho-
moserine lactone, and the C30 furanone inhibitor into 
the receptor active site using Molegro Virtual Docker 
(MVD Version 6.0). GTN was drawn into Marvin Sketch 
V5.11.5, 2013.
The most energetically favored conformer was saved as 
(*.mol2) file format for docking. The optimal geometry 
of  the ligand was determined during the docking process. 
The E monomer was chosen for analysis, water was re-
moved, cavities were detected and the search area was set 
to be  9 Å from the center of  the active site. Iterative sim-
plex algorithm was chosen to perform docking process 
with 10 runs per ligand, 200 population size, 1000 max 
iteration and 5 poses for each ligand. MolDock docking 
engine using docking template and the optimized ligands 
was executed24. Finally, the top returned poses were cho-
sen for analysis. The same docking procedures were fol-
lowed for docking GTN and the autoinducer, butanoyl 
homoserine lactone(C4HSL), into the active site of  the 
rhlr receptor model.
Statistical analysis
The effects of  GTN on virulence factors and biofilm for-
mation and eradication in P. aeruginosa were compared by 
One Way ANOVA followed by Dunnett’s Multiple Com-
parison Test, Graph Pad Prism 5. The effect on oxidative 
stress and violacein production was analyzed using un-




Strong biofilm formation capacity was found with clinical 
strains as the OD was higher than 4ODc (0.272) (Table 
1). PAO1 strain is a well known strong biofilm forming 
strain.
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Biofilm inhibition and eradication activities of  GTN
Sub-inhibitory concentration of  GTN (0.25 mg/ ml that 
corresponds to atleast¼ MIC) showed significant biofilm 
inhibiting activity against tested strains (p< 0.05). The 
inhibition ranged between 61% with PAO1 strain and 
92.26% with clinical isolate PA4. The biofilm eradicating 
activity was lower but still significant (p< 0.05) (Fig. 1). 
GTN biofilm removal capacity ranged between 28.51% 
and 66.52% with PA3 strain and PAO1, respectively.
Figure 1.(a) Inhibition of  biofilm formation by GTN, (b) eradication of  established biofilms by GTN. 
The error bars indicate the standard deviations of  two measurements
1112
Table 1. Biofilm assay of Pseudomonas aeruginosa strains 
 







Inhibition of   violacein production
The effect of  GTN on inhibition of  quorum sensing-
dependent violacein production in the biosensor strain 
Chromobacterium violaceum ATCC 12472 was statistically 
significant (p<0.05). GTN could  inhibit violacein  pro-
duction  by 70.08%.
 
This confirms the anti-quorum sensing  activity of  GTN.
Protease inhibition assay
GTN significantly reduced protease production (p< 0.05). 
The percentage of  inhibition ranged between 52.87% 
with PA3 and 78.53% with PAO1 (Fig. 2).
 
Pyocyanin inhibition assay
Pyocyanin  inhibition  by  GTN  was statistically signifi-
cant (p< 0.05) and ranged between 48.05% with PA5 and 
74.93% with PAO1 (Fig. 3).
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Figure 2. Inhibition of  protease by GTN. The error bars indicate the standard deviations of  three measurements 
Figure 3. Inhibition of  pyocyanin production by GTN. The error bars indicate the standard 
deviations of  three measurements 
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Oxidative stress assay
GTN was found to significantly increase the inhibitory 
effect of  hydrogen peroxide (p< 0.05) (Fig. 4). The diam-
eters of  inhibition zones were 26±2 mm (mean±SD) and 
40±2 in the absence and presence of   GTN, respectively. 
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Docking study
Molecular docking study was anticipated to interpret the 
mode of  binding interaction of  the GTN to the quorum 
sensing proteins LasR and rhlr at the molecular level. The 
natural ligand, GTN and the inhibitor C30 furanone new 
were docked into LasR active site. The binding interac-
tion between GTN and the receptor is attributed to H-
bonding with Tyr56, Trp60, Thr75, Tyr93, Thr115 and 
Ser129 (Fig. 5). The C30 furanone, a known inhibitor to 
LasR, was found to bind through H- bond with Trp60 
and Arg 61, while the natural ligand makes H-bond with 
Tyr56, Trp60, Asp73 and Ser129. The MolDock score 
of  GTN, C30 furanone  and  the  natural  ligand  were 
-93.472, -80.468 and -164.498. The inhibitor is unable to 
induce the correct formation of  the hydrophobic core of  
LasR. This conformational change is important for LasR 
activity22. The natural ligand is a LasR inducer as it can 
stabilize this conformational change through its long acyl 
chain, while GTN and C30 destabilize the protein core. 
Thus GTN and C30 furanone produce LasR antagonistic 
activity.
Figure 5. The Molecular docking of  a) GTN into the active site of  LasR enzyme 3D (Top) 
and 2D schematic view of  the binding (Bottom), b) natural ligand (Top) and C30 furanone 
(Bottom) into the active site of  LasR enzyme 3D (Left) and 2D schematic view of  the binding (Right)
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Figure 4. Resistance of  Pseudomonas aeruginosa PAO1 strain to oxidative stress in absence (a) and 
presence (b) of  GTN. The zone of  inhibition of  growth of  PAO1 by hydrogen peroxide increased 
in the presence of  GTN
Docking of  GTN into rhlr receptor model active site 
showed similar interaction to the auoinducer C4HSL (Fig. 
6). Both make H-bond with Trp108 and Arg112. C4HSL 
shows an extra H-bond with the carbonyl backbone of  
Leu112. These interactions resulted in binding energy of  
-77.23 and -85.24 for GTN and C4HSL respectively. The 
acyl group of  C4HSL is an  important factor for an in-
ducer that is absent in GTN which makes it a possible 
inhibitor. 
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Figure 6. The Molecular docking of  C4-BHL (Top) and GTN (Bottom) into the active site of  
rhlr receptor model 3D (Left) and 2D schematic view of  the binding (Right)
Discussion
The role of  quorum sensing in the control of  the viru-
lence made it an attractive target for new anti-virulence 
agents that can be used to treat infections. Many stud-
ies on QS inhibition in Gram negative bacteria tested the 
ability of  structural homologues of  QS autoinducers to 
interfere with binding of  these autoinducers to their re-
ceptors resulting in QS inhibition25.
The high toxicity of  most QSIs hinders their use in the 
treatment of  infections25. As a result, it is beneficial to 
search for new QSIs among FDA approved drugs that 
makes their clinical application possible. This rationale 
has been used in previous studies. As a result, a num-
ber of  useful quorum sensing inhibitors have been found 
among FDA approved drugs such as niclosamide, aspirin 
and diclofenac sodium26-28.
In this study, glyceryl trinitrate at a sub-inhibitory con-
centration was investigated for its activity against quorum 
sensing and some of  QS-regulated virulence factors such 
as pyocyanin, protease in addition to tolerance to oxida-
tive stress and biofilm formation.
GTN could inhibit the violacein pigment production that 
is  under  quorum-sensing  control in the reporter strain 
Chromobacterium violaceum ATCC 12472. This constitutes 
the biological evidence of  the quorum sensing inhibit-
ing activity of  GTN. Moreover, molecular docking study 
showed that GTN is a competitive inhibitor of  the natu-
ral ligands of  LasR and rhlR receptors; namely 3-oxo-
C12-HSL and C4-HSL, respectively. Consequently, GTN 
could  inhibit  the binding of  these autoinducers to their 
receptors resulting in quorum sensing inhibition. GTN 
showed higher quorum sensing inhibiting activity than 
the classical quorum sensing inhibition C30 furanone29 as 
competitive inhibitors of  3-oxo-C12- HSL as shown by 
lower docking score of  GTN than that of  C30 furanone. 
It also showed strong inhibiting activities against some 
QS-controlled virulence factors such as pyocyanin and 
protease production. Moreover, it could inhibit and eradi-
cate the established biofilms. This is an additional proof  
of  the anti-QS activity of  GTN due to the involvement 
of  QS system in biofilm formation and development30. 
GTN significantly reduced the tolerance of  Pseudomonas 
aeruginosa PAO1 strain to oxidative stress. This may be 
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due to the inhibition of  QS that is directly related to the 
tolerance to oxidative stress in P. aeruginosa. QS enables 
P. aeruginosa to inhibit phagocytosis and intracellular kill-
ing by oxygen radicals in neutrophils31. Moreover, QS-
deficient mutants produce lower amounts of  catalase and 
superoxide dismutase and they are more susceptible to 
oxidative stress than the wild strain32.
GTN is safe for topical application, and even   if  systemic 
absorption occurs, GTN has a very short half-life (1 to 3 
min), so any systemic effects are transient. Bolus doses of  
200 g of  GTN have been well tolerated and had no clini-
cally significant adverse effects33-36.
Conclusion
GTN is a novel QSI and antivirulence drug that is ap-
proved by FDA for human use. It can be used topically 
for treatment of  the highly resistant Pseudomonas aeruginosa 
topical infections such as burn infections.
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